Literature DB >> 9223277

X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release.

B Gigant1, J B Charbonnier, Z Eshhar, B S Green, M Knossow.   

Abstract

The x-ray structures of the unliganded esterase-like catalytic antibody D2.3 and its complexes with a substrate analogue and with one of the reaction products are analyzed. Together with the structure of the phosphonate transition state analogue hapten complex, these crystal structures provide a complete description of the reaction pathway. At alkaline pH, D2.3 acts by preferential stabilization of the negatively charged oxyanion intermediate of the reaction that results from hydroxide attack on the substrate. A tyrosine residue plays a crucial role in catalysis: it activates the ester substrate and, together with an asparagine, it stabilizes the oxyanion intermediate. A canal allows facile diffusion of water molecules to the reaction center that is deeply buried in the structure. Residues bordering this canal provide targets for mutagenesis to introduce a general base in the vicinity of the reaction center.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223277      PMCID: PMC21519          DOI: 10.1073/pnas.94.15.7857

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Detection, delineation, measurement and display of cavities in macromolecular structures.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-03-01

2.  The enzymic nature of antibody catalysis: development of multistep kinetic processing.

Authors:  S J Benkovic; J A Adams; C L Borders; K D Janda; R A Lerner
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

3.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

4.  At the crossroads of chemistry and immunology: catalytic antibodies.

Authors:  R A Lerner; S J Benkovic; P G Schultz
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

5.  catELISA: a facile general route to catalytic antibodies.

Authors:  D S Tawfik; B S Green; R Chap; M Sela; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

6.  Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.

Authors:  R Schier; A McCall; G P Adams; K W Marshall; H Merritt; M Yim; R S Crawford; L M Weiner; C Marks; J D Marks
Journal:  J Mol Biol       Date:  1996-11-08       Impact factor: 5.469

7.  Major antigen-induced domain rearrangements in an antibody.

Authors:  R L Stanfield; M Takimoto-Kamimura; J M Rini; A T Profy; I A Wilson
Journal:  Structure       Date:  1993-10-15       Impact factor: 5.006

Review 8.  Hydrolytic antibodies: variations on a theme.

Authors:  G MacBeath; D Hilvert
Journal:  Chem Biol       Date:  1996-06

9.  Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.

Authors:  J B Charbonnier; E Carpenter; B Gigant; B Golinelli-Pimpaneau; Z Eshhar; B S Green; M Knossow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

10.  Crystal structure of a catalytic antibody with a serine protease active site.

Authors:  G W Zhou; J Guo; W Huang; R J Fletterick; T S Scanlan
Journal:  Science       Date:  1994-08-19       Impact factor: 47.728

View more
  7 in total

1.  Catalysis of esterolytic reactions by the anti-idiotypic antibody against human erythrocyte acetylcholinesterase.

Authors:  E S Alexandrova; F Koralewski; M I Titov; A V Demin; A N Ignatova; A V Kozyr; A V Kolesnikov; A Tramontano; S Paul; D Thomas; A G Gabibov; A Friboulet
Journal:  Dokl Biochem Biophys       Date:  2001 Mar-Apr       Impact factor: 0.788

2.  Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.

Authors:  Sanjiv Sonkaria; Guillaume Boucher; José Flórez-Olvarez; Bilal Said; Syeed Hussain; Elizabeth L Ostler; Sheraz Gul; Emrys W Thomas; Marina Resmini; Gerard Gallacher; Keith Brocklehurst
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

3.  Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.

Authors:  Frédéric Eghiaian; Jeanne Grosclaude; Stéphanie Lesceu; Pascale Debey; Bénédicte Doublet; Eric Tréguer; Human Rezaei; Marcel Knossow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

4.  Structure and catalytic mechanism of the thioesterase CalE7 in enediyne biosynthesis.

Authors:  Masayo Kotaka; Rong Kong; Insaf Qureshi; Qin Shi Ho; Huihua Sun; Chong Wai Liew; Lan Pei Goh; Peter Cheung; Yuguang Mu; Julien Lescar; Zhao-Xun Liang
Journal:  J Biol Chem       Date:  2009-04-08       Impact factor: 5.157

5.  Molecular mechanism of enantioselective proton transfer to carbon in catalytic antibody 14D9.

Authors:  Lei Zheng; Ulrich Baumann; Jean-Louis Reymond
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

Review 6.  Mining electron density for functionally relevant protein polysterism in crystal structures.

Authors:  James S Fraser; Colin J Jackson
Journal:  Cell Mol Life Sci       Date:  2010-12-29       Impact factor: 9.261

7.  Beyond new chemical entities: advancing drug development based on functional versatility of antibodies.

Authors:  Salvador Eugenio C Caoili
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.